Lexaria Bioscience Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lexaria bioscience company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lexaria Bioscience Company Profile Today - Breaking & Trending Today

Cowen AND Company LLC Purchases New Holdings in Lexaria Bioscience Corp. (NASDAQ:LEXX)

Cowen AND Company LLC purchased a new position in shares of Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 256,327 shares of the company’s stock, valued at approximately $320,000. Cowen AND Company LLC owned about 2.46% of […] ....

Lexaria Bioscience , Armistice Capital , Lexaria Bioscience Company Profile , Lexaria Bioscience Corp , Maxim Group , Free Report , Get Free Report , Visit Holdingschannel , Lexaria Bioscience Daily ,

FY2024 Earnings Forecast for Lexaria Bioscience Corp. Issued By Zacks Small Cap (NASDAQ:LEXX)

Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) – Research analysts at Zacks Small Cap lifted their FY2024 earnings estimates for shares of Lexaria Bioscience in a research report issued on Monday, April 29th. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will earn ($0.46) per share for the year, up from their […] ....

Lexaria Bioscience , Lexaria Bioscience Company Profile , Lexaria Bioscience Corp , Welch Group , Armistice Capital , Maxim Group , Free Report , Zacks Small Cap , Small Cap , Get Free Report , Lexaria Bioscience Daily , Nasdaq Lexx , Earnings Estimates ,

Lexaria Bioscience Corp. (NASDAQ:LEXX) Position Raised by Invenomic Capital Management LP

Invenomic Capital Management LP raised its stake in Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) by 62.0% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 766,573 shares of the company’s stock after buying an additional 293,470 shares during the quarter. Invenomic Capital Management LP owned approximately 9.48% […] ....

Lexaria Bioscience , Susquehanna International Group , Virtu Financial , Lexaria Bioscience Corp , Dimensional Fund Advisors , Lexaria Bioscience Company Profile , Renaissance Technologies , Invenomic Capital Management , Free Report , Capital Management , International Group , Fund Advisors , Bioscience Stock Down , Visit Holdingschannel , Lexaria Bioscience Daily , Nasdaq Lexx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Lexaria Bioscience Corp. (NASDAQ:LEXX) Short Interest Up 14.5% in September

Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Free Report) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 422,900 shares, an increase of 14.5% from the September 15th total of 369,200 shares. Approximately 5.8% of the shares of the company are […] ....

Lexaria Bioscience , Lexaria Bioscience Corp , Susquehanna International Group , Virtu Financial , Dimensional Fund Advisors , Lexaria Bioscience Company Profile , Renaissance Technologies , Maxim Group , Get Free Report , Fund Advisors , International Group , Lexaria Bioscience Daily , Nasdaq Lexx ,

Lexaria Bioscience (OTCMKTS:LXRP) Stock Passes Above 50 Day Moving Average of $0.22

Shares of Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.22 and traded as high as $0.25. Lexaria Bioscience shares last traded at $0.22, with a volume of 2,151,500 shares. Lexaria Bioscience Stock Performance The firm […] ....

Lexaria Bioscience , Lexaria Bioscience Corp , Lexaria Bioscience Company Profile , Get Free Report , Lexaria Bioscience Daily , Otcmkts Lxrp ,